StockUK listing UKBVCLSEHealthcareEarnings Deterioration

Batm Advanced Communications Ltd(BVC) Stock Analysis | Healthcare

GBX --+0.00%
Reward39Moderate
Risk47Moderate
75%Data
Thin -16% profit margin · Revenue down 31% YoY
GBX —+0.00 (+0.00%) Previous close · LSE
Market cap 38.60M
Reward Ratingⓘ39 Moderate reward assessment · 75% data coverage
Bottom 5% of stocksView factors
Risk Ratingⓘ47 Moderate risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on BVC to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Batm Advanced Communications Ltd?

, together with its subsidiaries, engages in the development, production, and supply of real-time technologies and associated services in Israel, the United States, and Europe.

AI Brief Pro

The brief on Batm Advanced Communications Ltd

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Batm Advanced Communications Ltd?

, together with its subsidiaries, engages in the development, production, and supply of real-time technologies and associated services in Israel, the United States, and Europe. It operates through four segments: Cyber, Networking, Diagnostics, and Non-core. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 38.60M.

Financial Highlights

Investment Breakdown

Growth
Revenue growth is subdued, limiting near-term earnings expansion.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (39)

Similar stocks to compare

A short list of Medical Instruments & Supplies names that are close enough in size to make side-by-side comparison useful.

All Healthcare stocks →
Company Information
IndustryMedical Instruments & Supplies
Beta0.749
Insider Activity
12M windowAwaiting coverage
LSE director-dealings coverage launching later this year. The data feed is in development.